HomeZVSA • NASDAQ
add
Zyversa Therapeutics Inc
Previous close
$4.49
Day range
$4.20 - $4.72
Year range
$4.20 - $180.07
Market cap
3.23M USD
Avg Volume
375.23K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 2.83M | -38.45% |
Net income | -2.83M | 20.24% |
Net profit margin | — | — |
Earnings per share | -4.53 | — |
EBITDA | -2.82M | 38.47% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 2.03M | 59.11% |
Total assets | 21.65M | -81.17% |
Total liabilities | 10.43M | -41.60% |
Total equity | 11.22M | — |
Shares outstanding | 834.90K | — |
Price to book | 0.33 | — |
Return on assets | -32.29% | — |
Return on capital | -63.36% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -2.83M | 20.24% |
Cash from operations | -3.78M | 17.71% |
Cash from investing | — | — |
Cash from financing | 2.67M | 7,807.50% |
Net change in cash | -1.10M | 76.12% |
Free cash flow | -3.02M | 7.45% |
About
Founded
2014
Headquarters
Website
Employees
7